调脂治疗不稳定型心绞痛96例临床观察
Clinical observation of the treatment of 96 cases of unstable angina pectoris by regulation of blood fat
摘要
目的探讨洛伐他汀对不稳定型心绞痛(UA)患者的血脂、心脑缺血事件发生情况的影响。方法将UA患者96例分为常规治疗组(常规组)47例和洛伐他汀组(治疗组)49例,观察用药前后总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)及心脑缺血事件的发生频率。结果治疗组用药后血TC、TG和LDL-C明显下降(P<0.05),心脑缺血事件也比常规组明显降低(P<0.05)。结论UA患者早期、长期应用洛伐他汀药物治疗可明显降低心脑血管缺血事件的发生。
出处
《河北医药》
CAS
2005年第9期660-661,共2页
Hebei Medical Journal
参考文献7
-
1崔维,张东霞.洛伐他汀对高脂血症患者粘附分子的影响[J].中国全科医学,2003,6(12):995-996. 被引量:2
-
2茹祥伟,庞家亮.阿托伐他汀治疗混合型高脂血症的疗效观察[J].中国全科医学,2003,6(11):900-901. 被引量:12
-
3赖剑波,李毅夫,赵水平.HMG-COA还原酶抑制剂的抗血栓作用[J].岭南心血管病杂志,2001,7(3):214-215. 被引量:8
-
4李彦明,马振兴,靳巧娥.小剂量辛伐他汀对早期不稳定性心绞痛预后的影响[J].河北医药,2003,25(10):738-738. 被引量:1
-
5不稳定性心绞痛诊断和治疗建议[J].中华心血管病杂志,2000,28(6):409-412. 被引量:2696
-
6方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067
-
7周昭烈,叶庆华,张淇钏.阿托伐他汀治疗冠心病并高脂血症临床研究[J].河北医药,2003,25(5):328-329. 被引量:10
二级参考文献31
-
1Anderson, K M,Wilsce PWF,Odell PM,ct al. An updated coronary risk profile: A statement for heatlth prdessionals. Circulation, 1991,83 : 356.
-
2Nawrocki JW, Weiss SR, Davidson MH, et al. Reduction of LDL choleslerol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMC,-CoA reductase inhibitor.Arterioscler Thromb Vasc Biol, 1995,15:678-682.
-
3MAAS Investigators. Effect of simvastatin on coronary atheroma:The multicentre anti-atheroma study (MAAS). Lancet, 1994,344:633.
-
4Scandinavin Simvastatin Surviual study Croup. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival study(4s). Lancet,1995,345:1274.
-
5Davies M J, Richardson PD, Woolf N, et al. Risk of extrocellular Lipid, macrophaye,and smooth muscle cell content. Br Heart J, 1993,69:377.
-
6Driscoll Go,Green D,Taylor RR.Simvastatin,an HMG-coenzyme a reductase inhibitor,improves endothelial function within/month .Circulation,1997,95:1126.
-
7Blum CB. Comparison of properties of four inhibitors of 3 - hydroxy - 3-methylglutaryl-coenzyme A reductase. Am J Cardiol, 1994, 73:3-11.
-
8Bakker- Arkema RG. Davidson MH, Goldstein BJ, et al. Efficacy and safety of a new HMG - CoA reductase inhibitor, atorvastation, in patients with hypertrigly ceridemia. JAMA, 1996, 275 : 128 - 133.
-
9Haria M, Mc Tavish D. Properties and clinical effectiveness in the management of coronary heart disease. Drugs, 1997, 53:299 -336.
-
10Downs JR, Clearfield M, Whitney E, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. JAMA, 1998, 279:1615-1622.
共引文献5763
-
1翟优,邓林华,高丹,赵英强.血府逐瘀汤联合氯吡格雷对PCI术后CD62P、CD63、GPⅡb/Ⅲa及炎症因子的影响[J].中药材,2021,44(2):470-475. 被引量:15
-
2康艳生,刘静静,张伟,王彤,王晓琴,梁文,艾文婷.复方丹参颗粒、复方丹参胶囊、复方丹参片与复方丹参滴丸对冠心病心绞痛患者疗效、炎性因子及氧化应激指标的影响[J].药物评价研究,2020,0(2):287-292. 被引量:43
-
3黄莉姗,廖婉玲,骆青林.中药膏方益气活血膏结合美托洛尔对冠心病不稳定型心绞痛患者治疗效果及SDNN、RMSSD水平的影响[J].内蒙古中医药,2023,42(6):6-7. 被引量:6
-
4尹聪,程静,孙辉,李娟.中药注射液治疗不稳定型心绞痛对患者血脂水平影响系统评价和网状Meta分析[J].辽宁中医药大学学报,2021,23(8):179-189. 被引量:6
-
5杨慧君,孙瑞红.养心通络汤联合麝香通心滴丸治疗冠心病心绞痛的临床研究[J].辽宁中医杂志,2021,48(8):140-143. 被引量:3
-
6王姣.芪参益气滴丸联合单硝酸异山梨酯治疗心绞痛临床观察[J].光明中医,2020,0(2):267-269. 被引量:4
-
7荆智霞,韩晓莉.MDT术前访视在不稳定型心绞痛患者桡动脉入路PCI术围手术期中的应用[J].华夏医学,2019,0(6):86-89. 被引量:1
-
8周斌.葛根素注射液联合曲克芦丁注射液治疗不稳定型心绞痛的疗效观察[J].中国医师进修杂志,2011,34(S01):57-58.
-
9杜洪明,王燕,厉昌美,于文武.替格瑞洛联合阿托伐他汀对不稳定型心绞痛患者血液流变学及炎性因子水平的影响[J].反射疗法与康复医学,2023,4(7):132-135.
-
10王宇,邹恬.浅析谷红注射液治疗冠心病心绞痛临床效果[J].中国农村卫生,2019,11(14):26-26.